首页> 外国专利> road, the new endoteelisolun reseptorityrosiinikinaasi

road, the new endoteelisolun reseptorityrosiinikinaasi

机译:之路,新的内皮细胞受体酪氨酸激酶

摘要

The cloning, sequencing and expression of a novel receptor tyrosine kinase, termed tie, is described. The tie precursor comprises 1138 amino acid residues, about 1117 residues of which comprise the mature tie. The tie extracellular domain contains distinct stretches of amino acid sequence having features of the imunoglobulin, epidermal growth factor and fibronectin type III repeat protein families. Alternative splicing creates variants of tie which lack one of the epidermal growth factor homology domains. A specific tyrosine phosphorylated 117 kD glycoprotein is detected by specific tie-antisera from cultured cells expressing the tie gene. The tie mRNA is expressed in cultured endothelial cells as well as in a few tumor cell lines. In situ hybridization of human fetal and mouse embryonic tissues shows specific expression in endothelial cells of blood vessels. The tie DNAs and polypeptides of the invention may be useful in the diagnosis and treatment of certain diseases involving endothelial cells and their tie receptor such as neoplastic diseases involving tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammatory diseases.
机译:描述了一种新型的受体酪氨酸激酶(称为tie)的克隆,测序和表达。结合前体包含1138个氨基酸残基,其中约1117个氨基酸残基包含成熟的结合。紧密的胞外结构域包含不同的氨基酸序列,这些序列具有免疫球蛋白,表皮生长因子和纤连蛋白III型重复蛋白家族的特征。选择性剪接产生了领带的变体,其缺少表皮生长因子同源性域之一。特异性酪氨酸磷酸化的117 kD糖蛋白通过特异的结合抗血清从表达该基因的培养细胞中检测到。 tie mRNA在培养的内皮细胞以及一些肿瘤细胞系中表达。人胎儿和小鼠胚胎组织的原位杂交在血管内皮细胞中显示出特异性表达。本发明的结合DNA和多肽可用于诊断和治疗某些涉及内皮细胞及其结合受体的疾病,例如涉及肿瘤血管生成,伤口愈合,血栓栓塞性疾病,动脉粥样硬化和炎性疾病的肿瘤性疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号